Stock Comparison
GSK vs JNJ
GlaxoSmithKline PLC ADR and Johnson & Johnson side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$105.17B
$613.02B
P/E (TTM)
14.0
29.5
Forward P/E
22.1
22.0
Price/Sales
3.2
6.4
Price/Book
4.5
7.6
EV/EBITDA
9.4
19.2
Dividend Yield
3.43%
2.12%
Profitability
Net Margin
17.80%
21.80%
Operating Margin
36.30%
27.40%
Return on Equity
40.90%
26.40%
Return on Assets
10.00%
8.42%
Growth (YoY)
Revenue Growth
1.50%
9.90%
Earnings Growth
8.40%
-52.90%
Price & Risk
Beta
0.3
0.3
52-Week High
$60.65
$255.11
52-Week Low
$34.17
$147.81
Analyst Target
$56.63
$257.32
Compare GSK and JNJ your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.